Search published articles


Showing 2 results for Lichen Planus

Khatibi M, Ahmadinejad Z, Nasiri-Toosi M, Hajibaygi B, Zahedipour H,
Volume 66, Issue 8 (11-2008)
Abstract

Background: Hepatitis C is a major cause of chronic liver disease and hepatocellular carcinoma. Hepatitis C infection also has extrahepatic manifestations, including cryoglobulinemia and lichen planus. Lichen planus is a relatively common mucocutaneous disorder, and, due to its chronic pattern and increased incidence of malignancy, diagnosis and treatment of this disease are very important. The aim of the present study was to investigate the prevalence of oral lichen planus in HCV-infected patients.

Methods: In this cross sectional- descriptive study, the prevalence of oral lichen planus was evaluated by means of observation, clinical examination, questionnaire and evaluation of the medical records of 150 patients referred to the hepatitis clinic, gastrointentrology and infectious disease wards of Imam Khomeini Hospital and the Iran Blood Transfusion Organization, Tehran, Iran. We used a sequential method for sampling. Data were analyzed using statistical software (SPSS ver. 11) and the chi-square test.

Results: From a total 150 patients, 133 were male and 17 female. Six cases (4%) had oral lichen planus. All patients with oral lichen planus were male and the buccal mucosa was the most common site.

Conclusions: According to this study, the prevalence of oral lichen planus in patients afflicted with HCV is higher than in the normal population. We should pay more attention to oral lichen planus as one of the extrahepatic manifestations of hepatitis C.


Fateme Arbabi-Kalati , Mohammad-Mahdi Farahmand ,
Volume 75, Issue 9 (12-2017)
Abstract

Background: Lichen planus is an inflammatory mucocutaneous disease which involves 0.2‒4% of the population and has an unknown etiology. There is no definite treatment for the disease and current treatment modalities are palliative in nature. Although the exact cause of lichen planus is not clear, some scientists believe that free radicals and oxidative stress might have a role in causing this condition. The current study was conducted to assess the therapeutic effect of lycopene in treating erosive and atrophic oral lichen planus.
Methods: Thirty patients whose disease was confirmed by a pathologist were included in the clinical trial from January to July 2016 in the Department of Oral Medicine, Faculty of Dentistry, Zahedan University of Medical Sciences. The patients were randomly divided into two groups. The first group was treated with topical corticosteroid and 15 mg of systemic lycopene daily for a month and the second group received only topical corticosteroids. We recommended that the patients use the drugs (topical corticosteroids) four times a day, avoiding taking food for one hour after applying the drugs. Pain severity was recorded by numeric rating scale before and after the treatment and disease score was recorded by Thongprasom scale before and after treatment. Data were analyzed with SPSS 18. Mann-Whitney U test was used to compare the groups.
Results: In the case and control groups, pain scores before treatment were 5.4±1.2 and 5.7±0.9, with 3.01±1.8 and 3.2±1.5 after treatment, respectively. There was no significant difference between the two groups (P= 0.6, P= 0.4). Disease scores before treatment were 4.1±1 and 4±0.8, with 1.7±1.2 and 1.8±1.5 after treatment, respectively. There was no significant difference between the groups (P= 0.7, P= 0.8).
Conclusion: In this study the use of systemic lycopene did not increase the effect of topical corticosteroid; in addition, the results showed that the systemic use of 15 mg of lycopene in addition to topical corticosteroid treatment had no significant effect on patients’ pain and disease scores in comparison to topical corticosteroids.


Page 1 from 1     

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by : Yektaweb